Tag:
OncoVista Innovative Therapies
Latest Headlines
Latest Headlines
OncoVista to sell AdnaGen unit for up to $65M
OncoVista Innovative Therapies has divested its majority holding of its German subsidiary AdnaGen AG. As a result, the company will receive as much as $65 million in cash, enabling it to develop
